JD.COM INC (JD) — Hedge Fund Ownership Q1 2026
JD
- JD.COM INC (JD) is held by 5 of 84 tracked hedge funds, with Patient Capital Management (2%) and Appaloosa Management (1%) holding the largest stakes, indicating limited hedge fund interest relative to peers.
- The biggest increases in JD holdings came from Patient Capital Management (+66%), highlighting conviction.
- The biggest decreases in JD holdings came from Appaloosa Management (-69%) and Davis Selected Advisers (-14%), suggesting profit-taking or de-risking.
- Overall, hedge funds decreased exposure to JD.COM INC (JD) by -13% vs the prior quarter and -44% vs prior year.
| # | Fund | % of Portfolio † | Shares † | Shares vs Prior Quarter † | Shares vs Prior Year † | Aggregate Value † | Reported Price * | Option |
|---|---|---|---|---|---|---|---|---|
| 1 |
Patient Capital Management Samantha McLemore
|
1.54% | 1.4M | +66.41% | +78.07% | $41.4M | $29.57 | — |
| 2 |
Appaloosa Management
|
0.65% | 1.3M | -68.61% | -83.79% | $38.6M | $29.57 | — |
| 3 |
Dodge & Cox
|
0.20% | 12.2M | — | -32.49% | $360.6M | $29.57 | — |
| 4 |
Tiger Global Management Chase Coleman
|
0.04% | 344K | — | — | $10.2M | $29.57 | — |
| 5 |
Davis Selected Advisers Christopher Davis
|
0.04% | 283K | -13.91% | -17.96% | $8.4M | $29.57 | — |
| 5 | Total | — | 15.5M | -13.09% | -43.72% | $459.1M | — | — |
* Reported price is not an actual purchase or sale price. It is the price as of the last portfolio date.
† Portfolio value, share counts, and period-over-period changes exclude options positions (PUT/CALL), which are shown in the Option column for reference only.
† Portfolio value, share counts, and period-over-period changes exclude options positions (PUT/CALL), which are shown in the Option column for reference only.